Perfil
Bernd Schmidt is currently the Chief Technical Officer at Sensorion SA since 2023.
Prior to this, he worked as the Vice President-Product Delivery at Quell Therapeutics Ltd. Mr. Schmidt is a graduate of Friedrich-Alexander University of Erlangen-Nuremberg.
Cargos activos de Bernd Schmidt
| Empresas | Cargo | Inicio |
|---|---|---|
| SENSORION | Director Técnico/Científico/I+D | 11/12/2023 |
Antiguos cargos conocidos de Bernd Schmidt.
| Empresas | Cargo | Fin |
|---|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Formación de Bernd Schmidt.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- Bernd Schmidt
















